TY  - GEN
N2  - This study analyzes the efficacy of Nirmatrelvir and Ritonavir (NMV-r; Paxlovid) for outpatient treatment of COVID-19 in the pediatric population in the age group 12-18 years by using real-world data from N3C. The study uses propensity matching to create a treatment cohort and a control cohort. It further analyzes the clinical outcome such as hospitalization and ED visits following infection with COVID-19.
DO  - 10.6083/bpxhc43401
DO  - doi
AB  - This study analyzes the efficacy of Nirmatrelvir and Ritonavir (NMV-r; Paxlovid) for outpatient treatment of COVID-19 in the pediatric population in the age group 12-18 years by using real-world data from N3C. The study uses propensity matching to create a treatment cohort and a control cohort. It further analyzes the clinical outcome such as hospitalization and ED visits following infection with COVID-19.
AD  - Oregon Health and Science University
T1  - Studying the efficacy of Nirmatrelvir and Ritonavir (Paxlovid) for outpatient treatment of COVID-19 in the pediatric population using real-world data from the National COVID Cohort Collaborative (N3C)
ED  - Walker, Lorne
ED  - Advisor
DA  - 2024-06-16
AU  - Kumar, Manish
L1  - https://digitalcollections.ohsu.edu/record/43401/files/kumar.manish.2024.pdf
PB  - Oregon Health and Science University
LA  - eng
PY  - 2024-06-16
ID  - 43401
L4  - https://digitalcollections.ohsu.edu/record/43401/files/kumar.manish.2024.pdf
KW  - COVID-19
KW  - Ritonavir
KW  - propensity matching 
KW  - nirmatrelvir
KW  - paxlovid
TI  - Studying the efficacy of Nirmatrelvir and Ritonavir (Paxlovid) for outpatient treatment of COVID-19 in the pediatric population using real-world data from the National COVID Cohort Collaborative (N3C)
Y1  - 2024-06-16
L2  - https://digitalcollections.ohsu.edu/record/43401/files/kumar.manish.2024.pdf
LK  - https://digitalcollections.ohsu.edu/record/43401/files/kumar.manish.2024.pdf
UR  - https://digitalcollections.ohsu.edu/record/43401/files/kumar.manish.2024.pdf
ER  -